Pacific Biosciences Of California (PACB) Interest Expenses (2011 - 2026)

Pacific Biosciences Of California's Interest Expenses history runs 16 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• On a quarterly basis, Interest Expenses fell 0.85% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $7.4 million, a 35.07% decrease from a year earlier, with the FY2025 full-year figure at $679.0 million, up 21.51% from the prior year.
• Interest Expenses fell to $1.7 million in Q1 2026 per PACB's latest filing, from $2.2 million in the prior quarter.
• Across five years, Interest Expenses topped out at $27.4 million in Q3 2023 and bottomed at $1.2 million in Q4 2024.
• The 5-year median for Interest Expenses is $3.6 million (2023), against an average of $9.0 million.
• Across the five-year window, Interest Expenses soared 671.3% in 2024 and tumbled 93.66% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $2.5 million in 2022, then soared by 99.96% to $4.9 million in 2023, then plunged by 76.58% to $1.2 million in 2024, then surged by 91.14% to $2.2 million in 2025, then slipped by 20.91% to $1.7 million in 2026.
• Per Business Quant, the three latest PACB Interest Expenses figures stand at $1.7 million (Q1 2026), $2.2 million (Q4 2025), and $1.7 million (Q3 2025).